These two multicenter randomized clinical trials, sponsored by the National Institute of Health Research in the United Kingdom and the National Eye Institute, respectively, evaluate the relative efficacy and safety of Lucentis and Avastin in the management of neovascular age-related macular degeneration (AMD).
The presentation will also live-streamed at http://prolibraries.com/arvo/registration/event. While annual meeting registration is required for the session in Fort Lauderdale, the online is event is free.
The 2012 ARVO Annual Meeting, Translational Research: Seeing the Possibilities, takes place May 6 10 in Fort Lauderdale, Fla. Registration information can be found at www.arvo.org/am.
Provided by Association for Research in Vision and Ophthalmology
This Phys.org Science News Wire page contains a press release issued by an organization mentioned above and is provided to you “as is” with little or no review from Phys.Org staff.